시장보고서

상품코드

1485794

플라스미드 DNA 제조 시장 : 등급별, 용도별, 개발 단계별, 질환별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Plasmid DNA Manufacturing Market, By Grade, By Application, By Development Phase, By Disease, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 04월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 399 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

플라스미드 DNA 제조 시장 규모는 2023년에 17억 8,898만 달러에 달하며, 2024-2032년 CAGR 21.5%로 확대

플라스미드 DNA 제조 시장 - 시장 역학

연구개발 활동의 활발화, 유전성 질환 및 감염증의 유행의 증가가 시장 수요를 촉진

연구개발 활동 증가, 바이오 의약품에 대한 투자 증가, 유전자 이상 및 감염성 질환의 빈도 증가 등 다양한 이유가 플라스미드 DNA 제조 시장을 주도하고 있습니다. 또한 정밀의료의 발전과 새로운 면역치료제의 개발은 플라스미드 DNA 기반 의약품에 대한 수요를 증가시키고 있습니다. 규제 발전과 승인 절차의 단축은 시장 확대를 촉진하고 연구 발견을 보다 신속하게 임상 적용으로 전환할 수 있도록 돕고 있습니다.

플라스미드 DNA 제조 시장 - 주요 인사이트

AnalystView Market Insights의 리서치 애널리스트들의 분석에 따르면 세계 시장은 예측 기간(2024-2032) 동안 연평균 약 21.5%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

시장 세분화에 따르면 2023년에는 R&D 등급이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

용도별로는 DNA 백신이 2023년 주요 유형으로 부상할 것으로 예상됩니다.

개발 단계별로는 2023년에는 전임상 치료제가 주요 유형이 될 것으로 예상됩니다.

지역별로는 북미가 2023년 매출 1위

플라스미드 DNA 제조 시장 - 세분화 분석 :

세계 플라스미드 DNA 제조 시장은 등급, 용도, 개발 단계, 질병 및 지역에 따라 세분화됩니다.

시장은 등급별로 R&D 등급, GMP 등급, R&D 등급 분야가 시장을 독점하고 있습니다. 연구개발 초기 단계에서 널리 사용되는 R&D 등급 플라스미드 DNA는 과학자들이 새로운 치료 개념을 탐구하고 전임상 효능을 검증할 수 있게 해줍니다.

시장은 용도에 따라 DNA 백신, 세포 및 유전자 치료, 면역 치료, 기타로 나뉘며, DNA 백신 분야는 시장을 독점하고 있으며, 예측 기간 중에도 우위를 유지할 것으로 예상됩니다. 병원체를 인식하고 싸우는 면역체계의 능력을 활용하는 DNA 백신은 감염병을 예방하고 새로운 건강 위협에 대처할 수 있는 유망한 접근법을 제공합니다.

플라스미드 DNA 제조 시장 - 지역적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카으로 나뉩니다. 이 지역은 비즈니스를 가져 오는 국가에 따라 더 세분화됩니다.

플라스미드 DNA 제조 시장 - 경쟁상황 :

플라스미드 DNA 제조 시장은 경쟁이 치열하며, 유명한 경쟁업체들이 새로운 제조 공정과 확장 가능한 생산 능력으로 패권을 다투고 있습니다. 각 업체들은 전략적 제휴, 인수, R&D 비용을 통해 시장 지위를 강화하고 제품 라인업을 확대하기 위해 노력하고 있습니다. 주요 기업은 유전자 치료, 백신 연구, 바이오 의약품 제조 등 다양한 분야에서 증가하는 플라스미드 DNA 수요를 충족시키기 위해 품질 보증, 규제 준수, 비용 효율적인 솔루션을 우선순위에 두고 있습니다. 경쟁 우위를 유지하기 위해 기업은 끊임없이 변화하는 시장 동향과 고객 수요에 적응해야 합니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - 플라스미드 DNA 제조업계

경쟁 대시보드
기업 개요
- Nature Technology
- Cell and Gene Therapy Catapult
- Danaher(Aldevron)
- Kaneka Corp.
- Eurofins Genomics
- Lonza
- Charles River Laboratories
- VGXI, Inc.
- Luminous BioSciences, LLC
- Akron Biotech
- Others

제13장 애널리스트의 전방위 전망

KSA 24.06.05

REPORT HIGHLIGHT

Plasmid DNA Manufacturing Market size was valued at USD 1,788.98 Million in 2023, expanding at a CAGR of 21.5% from 2024 to 2032.

The Global Plasmid DNA Manufacturing Market is seeing substantial expansion and transition, owing to advances in biopharmaceutical study and development. Plasmid DNA, a flexible molecular tool, serves as the basis for a wide range of therapeutic applications, including DNA vaccinations, cell and gene therapy. As the need for personalised medicine and targeted therapies continues to develop, the market for plasmid DNA synthesis is positioned to significantly expand.

Plasmid DNA Manufacturing Market- Market Dynamics

Increasing research and development activities and the rising prevalence of genetic disorders and infectious diseases propel market demand

A variety of reasons are driving the Plasmid DNA Manufacturing marketplace, including increased R&D efforts, increased biopharmaceutical investments, and the rising frequency of genetic abnormalities and infectious illnesses. Furthermore, the move towards precision medicine and the development of new immunotherapies are driving up demand for plasmid DNA-based medicines. Regulatory advances and shortened approval procedures boost market expansion, allowing speedier translation of research discoveries into clinical applications.

Plasmid DNA Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.5% over the forecast period (2024-2032)

Based on Grade segmentation, R&D Grade was predicted to show maximum market share in the year 2023

Based on application segmentation, DNA Vaccines was the leading type in 2023

Based on Development Phase segmentation, Pre-Clinical Therapeutics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Plasmid DNA Manufacturing Market- Segmentation Analysis:

The Global Plasmid DNA Manufacturing Market is segmented based on Grade, Application, Development Phase, Disease, and Region.

The market is divided into three categories based on Grade: R&D Grade, GMP Grade. The R&D Grade sector dominates the market. Widely used in early-stage research and development, R&D Grade plasmid DNA enables scientists to explore novel therapeutic concepts and validate preclinical efficacy.

The market is divided into two categories based on application: DNA Vaccines, Cell & Gene Therapy, Immunotherapy, and Others. The DNA vaccine segment dominates the market and is likely to maintain its dominance during the forecast period. Leveraging the immune system's ability to recognize and combat pathogens, DNA vaccines offer a promising approach to preventing infectious diseases and addressing emerging health threats.

Plasmid DNA Manufacturing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Plasmid DNA Manufacturing Market- Competitive Landscape:

The Plasmid DNA Manufacturing Market is competitive, with prominent competitors vying for supremacy via novel manufacturing processes and scalable production capacity. Companies use strategic alliances, acquisitions, and R&D expenditures to strengthen their market position and broaden their product offerings. Leading companies prioritise quality assurance, regulatory compliance, and cost-effective solutions to fulfil the expanding demand for plasmid DNA in a variety of applications, including gene therapy, vaccine research, and biopharmaceutical manufacturing. To sustain their competitive advantage, businesses must constantly adapt to changing market trends and client demands.

Recent Developments:

In February 2023, PackGene Biotech expanded its services with the opening of an innovative GMP biomanufacturing and processing plant in Houston, Texas. This comprises gene therapy programmes that produce cost-effective, dependable, and scalable AAV products. With this development, the business hopes to become a one-stop solution supplier for gene therapy developers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMID DNA MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Nature Technology

Cell and Gene Therapy Catapult

Danaher (Aldevron)

Kaneka Corp.

Eurofins Genomics

Lonza

Charles River Laboratories

VGXI, Inc.

Luminous BioSciences, LLC

Akron Biotech

Others

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY GRADE- MARKET ANALYSIS, 2019 - 2032

R&D Grade
GMP Grade

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

DNA Vaccines
Cell & Gene Therapy
Immunotherapy
Others

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DEVELOPMENT PHASE- MARKET ANALYSIS, 2019 - 2032

Pre-Clinical Therapeutics
Clinical Therapeutics
Marketed Therapeutics

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

Infectious Disease
Cancer
Genetic Disorder
Others

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Plasmid DNA Manufacturing Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Plasmid DNA Manufacturing Market Snippet by Grade
- 2.1.2.Plasmid DNA Manufacturing Market Snippet by Development Phase
- 2.1.3.Plasmid DNA Manufacturing Market Snippet by Application
- 2.1.4.Plasmid DNA Manufacturing Market Snippet by Disease
- 2.1.5.Plasmid DNA Manufacturing Market Snippet by Country
- 2.1.6.Plasmid DNA Manufacturing Market Snippet by Region
2.2.Competitive Insights

3.Plasmid DNA Manufacturing Key Market Trends

3.1.Plasmid DNA Manufacturing Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Plasmid DNA Manufacturing Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Plasmid DNA Manufacturing Market Opportunities
3.4.Plasmid DNA Manufacturing Market Future Trends

4.Plasmid DNA Manufacturing Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Plasmid DNA Manufacturing Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Plasmid DNA Manufacturing Market Landscape

6.1.Plasmid DNA Manufacturing Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Plasmid DNA Manufacturing Market - By Grade

7.1.Overview
- 7.1.1.Segment Share Analysis, By Grade, 2023 & 2032 (%)
- 7.1.2.R&D Grade
- 7.1.3.GMP Grade

8.Plasmid DNA Manufacturing Market - By Development Phase

8.1.Overview
- 8.1.1.Segment Share Analysis, By Development Phase, 2023 & 2032 (%)
- 8.1.2.Pre-Clinical Therapeutics
- 8.1.3.Clinical Therapeutics
- 8.1.4.Marketed Therapeutics

9.Plasmid DNA Manufacturing Market - By Application

9.1.Overview
- 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2.DNA Vaccines
- 9.1.3.Cell & Gene Therapy
- 9.1.4.Immunotherapy
- 9.1.5.Others

10.Plasmid DNA Manufacturing Market - By Disease

10.1.Overview
- 10.1.1.Segment Share Analysis, By Development Phase, 2023 & 2032 (%)
- 10.1.2.Infectious Disease
- 10.1.3.Cancer
- 10.1.4.Genetic Disorder
- 10.1.5.Others

11.Plasmid DNA Manufacturing Market- By Geography

11.1.Introduction
- 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2.North America
- 11.2.1.Overview
- 11.2.2.Plasmid DNA Manufacturing Key Manufacturers in North America
- 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4.North America Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.2.5.North America Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7.North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.2.8.U.S.
  - 11.2.8.1.Overview
  - 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3.U.S. Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.2.8.4.U.S. Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.2.8.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.6.U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.2.9.Canada
  - 11.2.9.1.Overview
  - 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3.Canada Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.2.9.4.Canada Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.2.9.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.6.Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
11.3.Europe
- 11.3.1.Overview
- 11.3.2.Plasmid DNA Manufacturing Key Manufacturers in Europe
- 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4.Europe Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.3.5.Europe Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7.Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.8.Germany
  - 11.3.8.1.Overview
  - 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3.Germany Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.8.4.Germany Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.8.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.6.Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.9.Italy
  - 11.3.9.1.Overview
  - 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3.Italy Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.9.4.Italy Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.9.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.6.Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.10.United Kingdom
  - 11.3.10.1.Overview
  - 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3.United Kingdom Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.10.4.United Kingdom Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.10.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.6.United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.11.France
  - 11.3.11.1.Overview
  - 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3.France Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.11.4.France Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.11.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.6.France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.12.Russia
  - 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2.Russia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.12.3.Russia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.12.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.5.Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.13.Netherlands
  - 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2.Netherlands Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.13.3.Netherlands Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.13.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.5.Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.14.Sweden
  - 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2.Sweden Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.14.3.Sweden Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.14.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.5.Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.15.Poland
  - 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2.Poland Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.15.3.Poland Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.15.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.5.Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.16.Rest of Europe
  - 11.3.16.1.Overview
  - 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3.Rest of the Europe Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.16.4.Rest of the Europe Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.16.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.6.Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
11.4.Asia Pacific (APAC)
- 11.4.1.Overview
- 11.4.2.Plasmid DNA Manufacturing Key Manufacturers in Asia Pacific
- 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4.Asia Pacific Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.4.5.Asia Pacific Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7.Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.8.India
  - 11.4.8.1.Overview
  - 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3.India Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.8.4.India Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.8.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.6.India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.9.China
  - 11.4.9.1.Overview
  - 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3.China Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.9.4.China Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.9.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.6.China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.10.Japan
  - 11.4.10.1.Overview
  - 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3.Japan Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.10.4.Japan Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.10.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.6.Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.11.South Korea
  - 11.4.11.1.Overview
  - 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3.South Korea Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.11.4.South Korea Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.11.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.6.South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.12.Australia
  - 11.4.12.1.Overview
  - 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3.Australia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.12.4.Australia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.12.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.6.Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.13.Thailand
  - 11.4.13.1.Overview
  - 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3.Thailand Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.13.4.Thailand Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.13.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.6.Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.14.Indonesia
  - 11.4.14.1.Overview
  - 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3.Indonesia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.14.4.Indonesia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.14.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.6.Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.15.Philippines
  - 11.4.15.1.Overview
  - 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3.Philippines Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.15.4.Philippines Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.15.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.6.Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.16.Rest of APAC
  - 11.4.16.1.Overview
  - 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3.Rest of APAC Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.16.4.Rest of APAC Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.16.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.6.Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
11.5.Latin America
- 11.5.1.Overview
- 11.5.2.Plasmid DNA Manufacturing Key Manufacturers in Latin America
- 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4.Latin America Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.5.5.Latin America Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7.Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.8.Brazil
  - 11.5.8.1.Overview
  - 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3.Brazil Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.8.4.Brazil Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.8.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.6.Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.9.Mexico
  - 11.5.9.1.Overview
  - 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3.Mexico Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.9.4.Mexico Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.9.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.6.Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.10.Argentina
  - 11.5.10.1.Overview
  - 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3.Argentina Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.10.4.Argentina Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.10.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.6.Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.11.Colombia
  - 11.5.11.1.Overview
  - 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3.Colombia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.11.4.Colombia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.11.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.6.Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.12.Rest of LATAM
  - 11.5.12.1.Overview
  - 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3.Rest of LATAM Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.12.4.Rest of LATAM Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.12.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.6.Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
11.6.Middle East and Africa
- 11.6.1.Overview
- 11.6.2.Plasmid DNA Manufacturing Key Manufacturers in Middle East and Africa
- 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4.Middle East and Africa Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.6.5.Middle East and Africa Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7.Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.8.Saudi Arabia
  - 11.6.8.1.Overview
  - 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3.Saudi Arabia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.8.4.Saudi Arabia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.8.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.6.Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.9.United Arab Emirates
  - 11.6.9.1.Overview
  - 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3.United Arab Emirates Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.9.4.United Arab Emirates Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.9.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.6.United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.10.Israel
  - 11.6.10.1.Overview
  - 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3.Israel Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.10.4.Israel Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.10.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.6.Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.11.Turkey
  - 11.6.11.1.Overview
  - 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3.Turkey Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.11.4.Turkey Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.11.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.6.Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.12.Algeria
  - 11.6.12.1.Overview
  - 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3.Algeria Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.12.4.Algeria Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.12.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.6.Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.13.Egypt
  - 11.6.13.1.Overview
  - 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3.Egypt Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.13.4.Egypt Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.13.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.6.Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.14.Rest of MEA
  - 11.6.14.1.Overview
  - 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3.Rest of MEA Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.14.4.Rest of MEA Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.14.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.6.Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Plasmid DNA Manufacturing Industry

12.1.Competitive Dashboard
12.2.Company Profiles
- 12.2.1.Nature Technology
- 12.2.2.Cell and Gene Therapy Catapult
- 12.2.3.Danaher (Aldevron)
- 12.2.4.Kaneka Corp.
- 12.2.5.Eurofins Genomics
- 12.2.6.Lonza
- 12.2.7.Charles River Laboratories
- 12.2.8.VGXI, Inc.
- 12.2.9.Luminous BioSciences, LLC
- 12.2.10.Akron Biotech
- 12.2.11.Others

13.360 Degree Analyst View

14.Appendix

14.1.Research Methodology
14.2.References
14.3.Abbreviations
14.4.Disclaimer
14.5.Contact Us